Abstract
Autism is four times more prevalent in males than females. To study whether this reflects a difference in genetic predisposition attributed to autosomal rare variants, we evaluated sex differences in effect size of damaging protein-truncating and missense variants on autism predisposition in 47,061 autistic individuals using a liability model with differing thresholds. Given the sex differences in the rates of cognitive impairment among autistic individuals, we also compared effect sizes of rare variants between individuals with and without cognitive impairment or motor delay. Although these variants mediated different likelihoods of autism with versus without cognitive or motor difficulties, their effect sizes on the liability scale did not differ significantly by sex exome wide or in genes sex-differentially expressed in the cortex. De novo mutations were enriched in genes with male-biased expression in the adult cortex, but these genes did not show a significant sex difference on the liability scale, nor did the liability conferred by these genes differ significantly from other genes with similar loss-of-function intolerance and sex-averaged cortical expression. Exome-wide female bias in de novo protein-truncating mutation rates on the observed scale was driven by high-confidence and syndromic autism-predisposition genes. In summary, autosomal rare and damaging coding variants confer similar liability for autism in females and males.
| Original language | English |
|---|---|
| Pages (from-to) | 599-614 |
| Number of pages | 16 |
| Journal | American Journal of Human Genetics |
| Volume | 112 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 6 Mar 2025 |
| Externally published | Yes |
| Publication type | A1 Journal article-refereed |
Funding
We thank the participants and investigators who contributed to the datasets of the Simons Foundation Powering Autism Research for Knowledge project, the Autism Sequencing Consortium (ASC), the Simons Simplex Collection, and the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH) project. This work was supported by the Simons Foundation Autism Research Initiative (SFARI) through grant RNAG/669 G10 9280 to H.M., V.W., and other principal investigators of the Autism Prenatal Sex Differences Consortium (APEX). The ASC received support from SFARI ( 574598 , 736613 , and 647371 to S.J.S.; 575097 to B.D. and K.R.; 573206 to M.E.T. and M.J.D.; 571009 to J.D.; and 606362 and 608540 to M.E.T., M.J.D., J.D.B., B.D., K.R., and S.J.S., all from the consortia author list), NHGRI ( HG008895 to M.J.D., S.G., and M.E.T. from the consortia author list), NIMH ( MH115957 and MH123155 to M.E.T.; MH111658 and MH057881 to B.D.; MH097849 , MH111661 , and MH100233 to J.D.B.; MH109900 and MH123184 to K.R.; MH111660 and MH129722 to M.J.D.; and MH111662 and MH100027 to S.J.S., all from the consortia author list), NICHD ( HD081256 and HD096326 to M.E.T. from the consortia author list), AMED ( JP21WM0425007 to N.O. from the consortia author list), and the Beatrice and Samuel Seaver Foundation . We thank the participants and investigators who contributed to the datasets of the Simons Foundation Powering Autism Research for Knowledge (SPARK) project, the Autism Sequencing Consortium (ASC), the Simons Simplex Collection (SSC), and the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH) project. This work was supported by the Simons Foundation Autism Research Initiative (SFARI) through grant RNAG/669 G10 9280 to H.M., V.W., and other principal investigators of the Autism Prenatal Sex Differences Consortium (APEX). The ASC received support from SFARI (574598, 736613, and 647371 to S.J.S.; 575097 to B.D. and K.R.; 573206 to M.E.T. and M.J.D.; 571009 to J.D.; and 606362 and 608540 to M.E.T., M.J.D., J.D.B., B.D., K.R., and S.J.S., all from the consortia author list), NHGRI (HG008895 to M.J.D., S.G., and M.E.T. from the consortia author list), NIMH (MH115957 and MH123155 to M.E.T.; MH111658 and MH057881 to B.D.; MH097849, MH111661, and MH100233 to J.D.B.; MH109900 and MH123184 to K.R.; MH111660 and MH129722 to M.J.D.; and MH111662 and MH100027 to S.J.S., all from the consortia author list), NICHD (HD081256 and HD096326 to M.E.T. from the consortia author list), AMED (JP21WM0425007 to N.O. from the consortia author list), and the Beatrice and Samuel Seaver Foundation. This research was funded in whole, or in part, by the Wellcome Trust (grant number 220540/Z/20/A). For the purpose of Open Access, the authors have applied a CC-BY public copyright licence to any Author Accepted Manuscript version from this submission.
Keywords
- ASC
- Autism Sequencing Consortium
- exome sequencing
- rare variant association
- Simons Foundation Powering Autism Research for Knowledge
- SPARK
ASJC Scopus subject areas
- Genetics
- Genetics(clinical)
Fingerprint
Dive into the research topics of 'Contribution of autosomal rare and de novo variants to sex differences in autism'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver